Sidley Resource
Swiss Life Sciences Briefing
Global Life Sciences in Switzerland
Recommended Reading
-
PublicationsGetting to Know Eva Von Mühlenen: Our Latest Digital Health Thought LeaderNovember 2021
-
Publications“Mission-Critical Risks” and the Fiduciary Duties of Directors of Life Sciences CompaniesNovember 2021
-
PublicationsHerring or Cheese? The Swiss/European Union Relationship Without an Institutional Framework AgreementSeptember 2021
-
PublicationsUK Supreme Court Unanimously Upholds Judgment in Favor of Servier in “Unlawful Means” CaseSeptember 2021
-
PublicationsForeign Fines Tax-deductible Only in Exceptional Cases under New Swiss Law from 2022June 2021
-
PublicationsTakeaways From the New EU Animal Health RegulationJune 2021
-
PublicationsCOVID Passports in the EU and SwitzerlandJune 2021
-
PublicationsBest Recall Practices – Part 3 – Consumer GoodsJune 2021
-
PublicationsSwitzerland: Unequal Treatment of Patients With Rare DiseasesMay 2021
-
PublicationsSwitzerland: Public Consultation on Draft of New In Vitro Diagnostic OrdinanceMay 2021
-
PublicationsSwiss Medical Devices Regulation: Federal Council Issues Last-Minute ChangesMay 2021
-
PublicationsPharma Opportunities in Post-Brexit UKMay 2021
-
PublicationsSwiss Data Protection Act — New Guidance by the Swiss RegulatorApril 2021
-
PublicationsBest Recall Practices Guidelines — Part 2 — Food ProductsApril 2021
-
PublicationsBest Recall Practices Guidelines — Part 1 — Medical DevicesFebruary 2021
-
PublicationsPart 2: Revised to Match the EU General Data Protection Regulation — or AlmostFebruary 2021
-
PublicationsQuick Guide for Management of Data Integrity Breaches in a Clinical TrialFebruary 2021
-
PublicationsNational Institute for Health and Care Excellence Reinvented: Eyes on Innovation and Enhanced Patient AccessFebruary 2021
-
PublicationsRise of Environmental, Social, and Governance Due Diligence in EuropeFebruary 2021
-
PublicationsExport Restrictions on Medical Supply Amidst a PandemicFebruary 2021
-
PublicationsBrexit: Key Considerations for Swiss Pharmaceutical CompaniesDecember 2020
-
PublicationsManaging Contract Research Organizations and Common Risks in Outsourced Clinical TrialsDecember 2020
-
PublicationsSwiss Data Protection Act
Part 1: Revised to Live Up to the Digital AgeDecember 2020 -
Publications2020 – the Year of SPACsDecember 2020
-
PublicationsThe Nagoya Protocol's Impact on Research and DevelopmentNovember 2020
-
PublicationsCross-Border Data Flows and the Life Sciences Industry: How Trade Law Can HelpNovember 2020
-
PublicationsAdvertising by Mail-Order Pharmacies: Free Movement Rules of e-Commerce Directive Apply, Says European Court of JusticeOctober 2020
-
PublicationsInvestment Screening: Recent Developments With Implications for the Healthcare SectorOctober 2020
-
PublicationsThe End of the Swiss-U.S. Privacy Shield?September 2020
-
PublicationsSwitzerland: Update on Life Sciences Regulations — It’s Not All About COVID-19September 2020
-
PublicationsFacilitating Trade in Healthcare Products: the EU’s ProposalSeptember 2020
-
PublicationsSupply Chain Disruptions: Obtaining Effective Relief Through International ArbitrationJuly 2020
-
PublicationsLegality of Patent Settlement Agreements: The Jury’s Still OutJuly 2020
-
PublicationsChange of Control?July 2020
-
PublicationsHuman Rights and Environment: EU to Propose Legislation Requiring Due Diligence Through Supply ChainsMay 2020
-
PublicationsNew European Medicines Agency Guidance on Use of Software Tools in Clinical TrialsMay 2020
-
PublicationsFuture Developments in Clinical Studies: Clinical Trials in Countries with Emerging EconomiesApril 2020
-
PublicationsSwitzerland: COVID-19 Disrupts Well-Established Safeguards for Medicinal ProductsApril 2020
-
PublicationsClinical Trials in the EU: Ongoing Uncertainty Around Data Protection Compliance for SponsorsApril 2020
-
PublicationsOxygen for the Industry Providing Ventilators: EU Commission to Propose New Date for MDR ImplementationMarch 2020
-
PublicationsFuture Developments in Clinical Studies: Big Data AnalysisMarch 2020
-
PublicationsEU Whistleblowing Directive: What Life Sciences Companies Need to KnowMarch 2020
-
PublicationsProducts With Non-Medical Purpose — MDR Annex XVI Is LoomingFebruary 2020
-
PublicationsUnderstanding What Constitutes “Significant Changes” in Design and Intended Purpose of Medical Devices in the EUFebruary 2020
-
PublicationsContract Research Organizations: Ensuring That Sponsors of Clinical Studies Meet Their Oversight ObligationFebruary 2020
-
PublicationsData Integrity: Discover Anomalies Before Your Regulator DoesJanuary 2020
-
PublicationsContract Disputes Over Patents: Effective Dispute Resolution Through International ArbitrationJanuary 2020
-
PublicationsReplacement Compounding: A Major Threat to the Marketing Authorization SystemDecember 2019
-
PublicationsSoftware as Medical Device: New European Commission GuidanceDecember 2019
-
PublicationsNitrosamines: Swissmedic Guidance Requires New GMP/API FocusNovember 2019
-
PublicationsManage Your Disputes to Save Time and MoneyNovember 2019
-
PublicationsNew Swiss Rules on Clinical Evaluations and Investigations of Medical Devices: Important Changes Around the CornerNovember 2019
-
PublicationsWHO May Affect the National Pricing of Therapeutic ProductsNovember 2019
-
PublicationsTransparency vs. Confidentiality of Commercially Sensitive Information — A New Chapter Before EU CourtsNovember 2019
-
PublicationsWhen Pharma Met Medtech: Better and Faster Drug DiscoveryOctober 2019
-
PublicationsCould Private Equity Firms Help You Stay Competitive Following the New Swiss Medical Devices Regulation?October 2019
-
PublicationsInternational IP Arbitration - A Blessing or a Bad Idea?October 2019
-
PublicationsTraveling Healthily on the Belt and RoadSeptember 2019
-
PublicationsSwiss Medical Devices Manufacturers to Be Blocked by Missing Framework Agreement?September 2019
-
PublicationsEuropean Commission Issues Additional Medtech Vigilance GuidanceSeptember 2019
-
PublicationsRebooting the Harmonized System: An Opportunity for Life Sciences to Facilitate TradeSeptember 2019
-
PublicationsThe Extra-Territorial Reach of EU Data Protection LawJuly 2019
-
PublicationsEU Challenges Turkey with WTO Pharma DisputeJune 2019
-
PublicationsYour Life Sciences Investments in Cuba: A Time Bomb?June 2019
-
PublicationsProtecting Your International Contracts Through Effective Dispute Resolution ClausesJune 2019
-
PublicationsWarranty and Indemnity Insurance Opens Doors to Life Sciences DealsMay 2019
-
PublicationsProtecting Your Company Against Common Contract Failures Caused by External ChangeMay 2019
-
PublicationsTo Settle or Not To Settle? An Analysis of The Servier Patent Settlement Case and Its Practical ImplicationsMay 2019
-
PublicationsConsent For Personal Data Use In Clinical Trials: A Wind Of Regulatory Change?May 2019
-
PublicationsThe Last Piece of the Puzzle: Preventing Financial Influences on Healthcare Professionals’ Therapeutic DecisionsMay 2019
-
PublicationsContract Disputes Trends In Medtech: New Trends In Dispute Management To Save Time And MoneyMay 6, 2019
-
PublicationsConflict Management Strategies And Dispute Resolution Clauses – Ensuring Your International Contract Will Be EnforcedFebruary 4, 2019
-
PublicationsConflict Management Strategies: Protect Your Medtech Company Against Three Common Contract FailuresJanuary 14, 2019
Contact
If you have any questions regarding the content of these articles or suggestions for topics to be covered in future issues, please contact the Sidley lawyer with whom you usually work, or:
Editor
Capabilities
SERVICES AND INDUSTRIES
- Global Arbitration, Trade and Advocacy
- Global Life Sciences
- EU - Food, Drug and Medical Device Regulatory
GLOBAL REACH
Sidley Office
Stay Up To Date